BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 22378192)

  • 1. A human claudin-1-derived peptide inhibits hepatitis C virus entry.
    Si Y; Liu S; Liu X; Jacobs JL; Cheng M; Niu Y; Jin Q; Wang T; Yang W
    Hepatology; 2012 Aug; 56(2):507-15. PubMed ID: 22378192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of hepatitis C virus infection by anti-claudin-1 antibodies is mediated by neutralization of E2-CD81-claudin-1 associations.
    Krieger SE; Zeisel MB; Davis C; Thumann C; Harris HJ; Schnober EK; Mee C; Soulier E; Royer C; Lambotin M; Grunert F; Dao Thi VL; Dreux M; Cosset FL; McKeating JA; Schuster C; Baumert TF
    Hepatology; 2010 Apr; 51(4):1144-57. PubMed ID: 20069648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Piperazinylbenzenesulfonamides as New Inhibitors of Claudin-1 Trafficking and Hepatitis C Virus Entry.
    Riva L; Song OR; Prentoe J; Helle F; L'homme L; Gattolliat CH; Vandeputte A; Fénéant L; Belouzard S; Baumert TF; Asselah T; Bukh J; Brodin P; Cocquerel L; Rouillé Y; Dubuisson J
    J Virol; 2018 May; 92(10):. PubMed ID: 29491159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal anti-claudin 1 antibodies prevent hepatitis C virus infection of primary human hepatocytes.
    Fofana I; Krieger SE; Grunert F; Glauben S; Xiao F; Fafi-Kremer S; Soulier E; Royer C; Thumann C; Mee CJ; McKeating JA; Dragic T; Pessaux P; Stoll-Keller F; Schuster C; Thompson J; Baumert TF
    Gastroenterology; 2010 Sep; 139(3):953-64, 964.e1-4. PubMed ID: 20685314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The tight junction-associated protein occludin is required for a postbinding step in hepatitis C virus entry and infection.
    Benedicto I; Molina-Jiménez F; Bartosch B; Cosset FL; Lavillette D; Prieto J; Moreno-Otero R; Valenzuela-Fernández A; Aldabe R; López-Cabrera M; Majano PL
    J Virol; 2009 Aug; 83(16):8012-20. PubMed ID: 19515778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibodies against extracellular domains of claudin-1 block hepatitis C virus infection in a mouse model.
    Fukasawa M; Nagase S; Shirasago Y; Iida M; Yamashita M; Endo K; Yagi K; Suzuki T; Wakita T; Hanada K; Kuniyasu H; Kondoh M
    J Virol; 2015 May; 89(9):4866-79. PubMed ID: 25673725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry.
    Evans MJ; von Hahn T; Tscherne DM; Syder AJ; Panis M; Wölk B; Hatziioannou T; McKeating JA; Bieniasz PD; Rice CM
    Nature; 2007 Apr; 446(7137):801-5. PubMed ID: 17325668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of the tight junction-like distribution of Claudin-1 to the cellular tropism of hepatitis C virus.
    Yang W; Qiu C; Biswas N; Jin J; Watkins SC; Montelaro RC; Coyne CB; Wang T
    J Biol Chem; 2008 Mar; 283(13):8643-53. PubMed ID: 18211898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human apolipoprotein E peptides inhibit hepatitis C virus entry by blocking virus binding.
    Liu S; McCormick KD; Zhao W; Zhao T; Fan D; Wang T
    Hepatology; 2012 Aug; 56(2):484-91. PubMed ID: 22334503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polarization restricts hepatitis C virus entry into HepG2 hepatoma cells.
    Mee CJ; Harris HJ; Farquhar MJ; Wilson G; Reynolds G; Davis C; van IJzendoorn SC; Balfe P; McKeating JA
    J Virol; 2009 Jun; 83(12):6211-21. PubMed ID: 19357163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal Antibodies against Occludin Completely Prevented Hepatitis C Virus Infection in a Mouse Model.
    Shimizu Y; Shirasago Y; Kondoh M; Suzuki T; Wakita T; Hanada K; Yagi K; Fukasawa M
    J Virol; 2018 Apr; 92(8):. PubMed ID: 29437969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infection with hepatitis C virus depends on TACSTD2, a regulator of claudin-1 and occludin highly downregulated in hepatocellular carcinoma.
    Sekhar V; Pollicino T; Diaz G; Engle RE; Alayli F; Melis M; Kabat J; Tice A; Pomerenke A; Altan-Bonnet N; Zamboni F; Lusso P; Emerson SU; Farci P
    PLoS Pathog; 2018 Mar; 14(3):e1006916. PubMed ID: 29538454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.
    Liu X; Huang Y; Cheng M; Pan L; Si Y; Li G; Niu Y; Zhao L; Zhao J; Li X; Chen Y; Yang W
    J Virol; 2013 Feb; 87(3):1649-57. PubMed ID: 23175359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tight junction proteins claudin-1 and occludin control hepatitis C virus entry and are downregulated during infection to prevent superinfection.
    Liu S; Yang W; Shen L; Turner JR; Coyne CB; Wang T
    J Virol; 2009 Feb; 83(4):2011-4. PubMed ID: 19052094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of hypervariable region 1 for the interplay of hepatitis C virus with entry factors and lipoproteins.
    Bankwitz D; Vieyres G; Hueging K; Bitzegeio J; Doepke M; Chhatwal P; Haid S; Catanese MT; Zeisel MB; Nicosia A; Baumert TF; Kaderali L; Pietschmann T
    J Virol; 2014 Nov; 88(21):12644-55. PubMed ID: 25142595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The SR-BI partner PDZK1 facilitates hepatitis C virus entry.
    Eyre NS; Drummer HE; Beard MR
    PLoS Pathog; 2010 Oct; 6(10):e1001130. PubMed ID: 20949066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tupaia CD81, SR-BI, claudin-1, and occludin support hepatitis C virus infection.
    Tong Y; Zhu Y; Xia X; Liu Y; Feng Y; Hua X; Chen Z; Ding H; Gao L; Wang Y; Feitelson MA; Zhao P; Qi ZT
    J Virol; 2011 Mar; 85(6):2793-802. PubMed ID: 21177818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single Particle Imaging of Polarized Hepatoma Organoids upon Hepatitis C Virus Infection Reveals an Ordered and Sequential Entry Process.
    Baktash Y; Madhav A; Coller KE; Randall G
    Cell Host Microbe; 2018 Mar; 23(3):382-394.e5. PubMed ID: 29544098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Research on hepatitis C virus entry inhibitor].
    Zeng Wenting ; Lu X; Wang J; Jin X; Zhu J
    Bing Du Xue Bao; 2015 Jan; 31(1):97-105. PubMed ID: 25997338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Viral kinetics suggests a reconciliation of the disparate observations of the modulation of claudin-1 expression on cells exposed to hepatitis C virus.
    Padmanabhan P; Dixit NM
    PLoS One; 2012; 7(4):e36107. PubMed ID: 22545157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.